PWR
49
2
REGN
36
-4
COF
45
5
DOV
59
2
DNB
40
2
CNX
46
-2
KMB
48
-3
K
59
2
EA
54
-5
PG
61
-7
DRI
66
3
PNC
52
3
IPG
48
-5
CHD
51
-7
SJM
28
-6
BIIB
39
-3
TXT
46
-2
TSCO
46
-3
IRM
41
7
GOOG
55
5
PWR
49
2
REGN
36
-4
COF
45
5
DOV
59
2
DNB
40
2
CNX
46
-2
KMB
48
-3
K
59
2
EA
54
-5
PG
61
-7
DRI
66
3
PNC
52
3
IPG
48
-5
CHD
51
-7
SJM
28
-6
BIIB
39
-3
TXT
46
-2
TSCO
46
-3
IRM
41
7
GOOG
55
5
Financhill
Back

Akebia Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
29

AKBA
Akebia Therapeutics

Last Price:
$1.56
Seasonality Move:
-12.09%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.65
Seasonality Move:
6.73%
Sell
29
Akebia Therapeutics (AKBA) is a Sell

Is Akebia Therapeutics a Buy, Sell or Hold?

  • The current Akebia Therapeutics [AKBA] share price is $1.93. The Score for AKBA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • AKBA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AKBA Stock Price Chart

What is Akebia Therapeutics's stock price today?

  • The Akebia Therapeutics share price today is $1.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKBA is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

AKBA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 48.89 Sell
Chaikin Money Flow: -1739832 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.84 - 2.12) Sell
Bollinger Bands (100): (1.68 - 2.14) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

AKBA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.88 Buy
20-day SMA: 1.94 Sell
50-day SMA: 2.02 Sell
200-day SMA: 1.58 Buy
8-day EMA: 1.9 Buy
20-day EMA: 1.94 Sell
50-day EMA: 1.96 Sell
200-day EMA: 1.7 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Akebia Therapeutics Earnings Growth & AKBA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.24 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Akebia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):